Physician profile
John W Fanning
NPI 1306813571
$6,137.81
in general payments reported to CMS, 2019-2025
12 companies · $847 in 2025
The $847 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $550 · 2021: $1,735 · 2022: $100 · 2023: $2,076 · 2024: $89.43 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,653 · Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,653.29 |
| Food and Beverage | $1,358.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $1,726.55 | 2021-2025 | |
| Arthrex, INC. | $1,696.96 | 2021-2023 | |
| Treace Medical Concepts, INC. | $1,451.27 | 2019-2025 | |
| Stryker Corporation | $572.57 | 2019-2025 | 7 X 23mm Citrelock Implant, Dart-Fire, Citrefix |
| Bard Peripheral Vascular, INC. | $235.91 | 2019-2020 | |
| Wright Medical Technology, INC. | $216.22 | 2019 | |
| Acumed LLC | $149.77 | 2025 | Acumed, Inframe Implant, Innate Implant |
| Lima USA, INC. | $25.30 | 2019 | |
| Smith+Nephew, INC. | $21.31 | 2019 | |
| Arthrosurface Incorporated | $15.55 | 2019 | |
| Integra Lifesciences Corporation | $14.50 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pfizer INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fanning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.